The first group uses the neuromuscular block drugs (43 patients: 34.6%), the seconds don't use them (81 patients: 65.4%).
Nhóm 1: 43 BN dùng TDC (34,6%), nhóm 2: 81 BN không dùng dãn cơ (KTDC) (65,4%).